Mercury Laboratories Limited (BOM:538964)
India · Delayed Price · Currency is INR 805.15
0.00 (0.00%)
At close: Feb 12, 2026
Mercury Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 761.53 | 751.01 | 755.59 | 753.34 | 579.24 | 686.02 |
| 761.53 | 751.01 | 755.59 | 753.34 | 579.24 | 686.02 | |
Revenue Growth (YoY) | 6.05% | -0.61% | 0.30% | 30.06% | -15.57% | 19.79% |
Cost of Revenue | 312.05 | 303.9 | 324.27 | 328.94 | 247.77 | 322.43 |
Gross Profit | 449.49 | 447.11 | 431.32 | 424.39 | 331.46 | 363.59 |
Selling, General & Admin | 172.25 | 168.41 | 145.01 | 142.45 | 124.97 | 98 |
Other Operating Expenses | 182.6 | 205.14 | 192.71 | 189 | 134.96 | 159.23 |
Operating Expenses | 387.9 | 402.31 | 365.88 | 361.11 | 284.6 | 286.89 |
Operating Income | 61.59 | 44.8 | 65.44 | 63.28 | 46.87 | 76.7 |
Interest Expense | -2.14 | -2.16 | -0.65 | -0.57 | -1.7 | -2.54 |
Interest & Investment Income | 0.94 | 0.94 | 1.2 | 1.24 | 0.88 | 0.58 |
Currency Exchange Gain (Loss) | 4.46 | 4.46 | 3.55 | 12.4 | 4.31 | 2.73 |
Other Non Operating Income (Expenses) | 2.05 | -1.95 | -1.01 | -1.63 | -1.52 | 1.55 |
EBT Excluding Unusual Items | 66.89 | 46.09 | 68.53 | 74.71 | 48.84 | 79.02 |
Gain (Loss) on Sale of Assets | 0.53 | 0.53 | 0.68 | -0.27 | 0.23 | - |
Other Unusual Items | -3.95 | - | - | - | 1.28 | - |
Pretax Income | 63.47 | 46.62 | 69.2 | 74.45 | 50.34 | 79.09 |
Income Tax Expense | 16.28 | 15.17 | 12.66 | 18.66 | 14.73 | 25.72 |
Net Income | 47.19 | 31.45 | 56.54 | 55.79 | 35.62 | 53.38 |
Net Income to Common | 47.19 | 31.45 | 56.54 | 55.79 | 35.62 | 53.38 |
Net Income Growth | 19.61% | -44.38% | 1.35% | 56.62% | -33.27% | 65.34% |
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 1 | 1 |
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 1 | 1 |
EPS (Basic) | 39.31 | 26.21 | 47.12 | 46.49 | 29.68 | 44.48 |
EPS (Diluted) | 39.31 | 26.21 | 47.12 | 46.49 | 29.68 | 44.48 |
EPS Growth | 19.57% | -44.38% | 1.35% | 56.64% | -33.27% | 65.34% |
Free Cash Flow | - | -50.39 | 19.53 | 13.96 | 32.74 | 35.95 |
Free Cash Flow Per Share | - | -41.99 | 16.28 | 11.63 | 27.29 | 29.95 |
Dividend Per Share | - | 3.500 | 3.500 | 3.500 | 3.500 | 3.500 |
Dividend Growth | - | - | - | - | - | 75.00% |
Gross Margin | 59.02% | 59.53% | 57.08% | 56.34% | 57.22% | 53.00% |
Operating Margin | 8.09% | 5.96% | 8.66% | 8.40% | 8.09% | 11.18% |
Profit Margin | 6.20% | 4.19% | 7.48% | 7.41% | 6.15% | 7.78% |
Free Cash Flow Margin | - | -6.71% | 2.58% | 1.85% | 5.65% | 5.24% |
EBITDA | 85.01 | 67.26 | 86.61 | 84.14 | 67.39 | 95.74 |
EBITDA Margin | 11.16% | 8.96% | 11.46% | 11.17% | 11.63% | 13.96% |
D&A For EBITDA | 23.42 | 22.46 | 21.17 | 20.86 | 20.52 | 19.04 |
EBIT | 61.59 | 44.8 | 65.44 | 63.28 | 46.87 | 76.7 |
EBIT Margin | 8.09% | 5.96% | 8.66% | 8.40% | 8.09% | 11.18% |
Effective Tax Rate | 25.66% | 32.54% | 18.30% | 25.06% | 29.25% | 32.51% |
Revenue as Reported | 776.22 | 761.7 | 766.48 | 770.53 | 587.4 | 694.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.